KCM
IBDQ

Kathmere Capital Management’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Kathmere Capital Management’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,229,636
Closed -$31M – 584
2025
Q3 		$31M Buy
1,229,636
+140,785
+13% +$3.54M 2.2% 9
2025
Q2 		$27.4M Buy
1,088,851
+44,905
+4% +$1.13M 2.11% 9
2025
Q1 		$26.3M Buy
1,043,946
+94,428
+10% +$2.37M 2.23% 9
2024
Q4 		$23.8M Sell
949,518
-114,527
-11% -$2.87M 2.13% 8
2024
Q3 		$26.7M Sell
1,064,045
-113,956
-10% -$2.84M 2.5% 8
2024
Q2 		$29.3M Buy
1,178,001
+166,439
+16% +$4.12M 3.1% 8
2024
Q1 		$25.1M Buy
1,011,562
+72,581
+8% +$1.8M 2.87% 8
2023
Q4 		$23.2M Buy
938,981
+928,526
+8,881% +$22.7M 3.01% 7
2023
Q3 		$255K Buy
+10,455
New +$255K 0.04% 217
2023
Q2 		– Sell
-15,710
Closed -$385K – 248
2023
Q1 		$385K Buy
15,710
+47
+0.3% +$1.15K 0.06% 130
2022
Q4 		$381K Buy
15,663
+79
+0.5% +$1.91K 0.07% 120
2022
Q3 		$376K Buy
15,584
+49
+0.3% +$1.21K 0.08% 106
2022
Q2 		$384K Buy
15,535
+43
+0.3% +$1.07K 0.07% 99
2022
Q1 		$391K Buy
15,492
+28
+0.2% +$722 0.07% 101
2021
Q4 		$409K Buy
15,464
+2,901
+23% +$77.1K 0.07% 83
2021
Q3 		$337K Buy
12,563
+41
+0.3% +$1.11K 0.06% 102
2021
Q2 		$338K Buy
12,522
+42
+0.3% +$1.13K 0.07% 101
2021
Q1 		$335K Buy
12,480
+2,552
+26% +$69.1K 0.07% 99
2020
Q4 		$272K Buy
9,928
+70
+0.7% +$1.9K 0.06% 99
2020
Q3 		$267K Buy
9,858
+52
+0.5% +$1.41K 0.07% 87
2020
Q2 		$265K Buy
9,806
+62
+0.6% +$1.63K 0.08% 90
2020
Q1 		$243K Buy
9,744
+1,167
+14% +$30.1K 0.09% 69
2019
Q4 		$222K Buy
+8,577
New +$222K 0.08% 105

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kathmere Capital Management's IBDQ Position: Q4 2025 in Review

Kathmere Capital Management sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 1,229,636 shares — an estimated $31M sold.

Kathmere Capital Management first reported a position in IBDQ in Q4 2019 and held it in 23 quarters. The position peaked at $31M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Kathmere Capital Management reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Kathmere Capital Management sold 1,229,636 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $31M.
  • Kathmere Capital Management first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2019 and held it in 23 quarters.
  • Kathmere Capital Management's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $31M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Kathmere Capital Management's 13F filing for Q4 2025, filed 13 Jan 2026.